Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-24-110087
Filing Date
2024-09-27
Accepted
2024-09-27 17:11:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 prospectus_supplement_no.htm 424B3 18818
2 GRAPHIC img150995122_0.jpg GRAPHIC 19587
  Complete submission text file 0000950170-24-110087.txt   46951
Mailing Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-281527 | Film No.: 241335931
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)